Literature DB >> 4098598

Passive anaphylaxis in mice with gamma-G antibodies. V. Competitive effects of different immunoglobulins and inhibition of reactions with antiglobulin sera.

Z Ovary, N M Vaz, N L Warner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4098598      PMCID: PMC1455639     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  16 in total

1.  IMMUNOLOGICAL SPECIFICITY OF THE SECONDARY RESPONSE WITH DINITROPHENYLATED PROTEINS.

Authors:  Z OVARY; B BENACERRAF
Journal:  Proc Soc Exp Biol Med       Date:  1963-10

2.  Studies of hypersensitivity to low molecular weight substances. III. The 2,4-dinitrophenyl group as a determinant in the preciptin reaction.

Authors:  H N EISEN; M E CARSTEN; S BELMAN
Journal:  J Immunol       Date:  1954-11       Impact factor: 5.422

3.  [Preventive action of normal rabbit serum on passive cutaneous anaphylaxis in the guinea pig].

Authors:  Z OVARY; O G BIER
Journal:  Ann Inst Pasteur (Paris)       Date:  1953-02

4.  A skin-sensitizing and thermolabile antibody in the mouse.

Authors:  I Mota; J M Peixoto
Journal:  Life Sci       Date:  1966-09       Impact factor: 5.037

Review 5.  The anaphylactic antibodies of mammals including man.

Authors:  K J Bloch
Journal:  Prog Allergy       Date:  1967

6.  Properties of antibodies cytophilic for macrophages.

Authors:  A Berken; B Benacerraf
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

7.  ELECTROPHORETIC SEPARATION AND PROPERTIES OF MOUSE ANTIHAPTEN ANTIBODIES INVOLVED IN PASSIVE CUTANEOUS ANAPHYLAXIS AND PASSIVE HEMOLYSIS.

Authors:  R S NUSSENZWEIG; C MERRYMAN; B BENACERRAF
Journal:  J Exp Med       Date:  1964-08-01       Impact factor: 14.307

8.  THE IMMUNOGLOBULINS OF MICE. 3. SKIN SENSITIZING ACTIVITY OF MOUSE IMMUNOGLOBULINS.

Authors:  Z OVARY; W F BARTH; J L FAHEY
Journal:  J Immunol       Date:  1965-03       Impact factor: 5.422

9.  Mouse homocytotropic antibodies. I. Specific differentiation between mouse 7S gamma 1 and mouse reagin-like antibodies.

Authors:  I Mota; D Wong; E H Sadun
Journal:  Life Sci       Date:  1968-12-15       Impact factor: 5.037

10.  Properties of guinea pig 7S antibodies. I. Electrophoretic separation of two types of guinea pig 7S antibodies.

Authors:  B BENACERRAF; Z OVARY; K J BLOCH; E C FRANKLIN
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

View more
  5 in total

1.  Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis.

Authors:  I Miyajima; D Dombrowicz; T R Martin; J V Ravetch; J P Kinet; S J Galli
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

2.  Comparison of mouse strain skin sensitivities to anaphylactic mediators and susceptibility to passive cutaneous anaphylactic reactions.

Authors:  D E Justus; C Saelinger
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

3.  Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.

Authors:  Nicole Schmitz; Klaus Dietmeier; Monika Bauer; Melanie Maudrich; Stefan Utzinger; Simone Muntwiler; Philippe Saudan; Martin F Bachmann
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

4.  Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen.

Authors:  J Saloga; H Renz; G Lack; K L Bradley; J L Greenstein; G Larsen; E W Gelfand
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

5.  Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice.

Authors:  A Oshiba; E Hamelmann; K Takeda; K L Bradley; J E Loader; G L Larsen; E W Gelfand
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.